D
4576
vs
ABBV
D
4576
ABBV
Over the past 12 months, D.Western Therapeutics Institute Inc has underperformed ABBV, delivering a return of -12% compared to the ABBV's +10% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
4576
ABBV
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
D.Western Therapeutics Institute Inc Intrinsic Value
HIDDEN
ABBV Intrinsic Value
HIDDEN
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc
TSE:4576
|
100
JPY
|
|||||
|
Abbvie Inc
NYSE:ABBV
|
231.675
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
4576, ABBV
4576, ABBV
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
D
|
D.Western Therapeutics Institute Inc
Revenue
|
|||||||||||
|
|
Abbvie Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
4576, ABBV
4576, ABBV
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
D
|
D.Western Therapeutics Institute Inc
TSE:4576
|
|||||||||
|
|
Abbvie Inc
NYSE:ABBV
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
D.Western Therapeutics Institute Inc
90%
ABBV
71.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc | ||||
|
|
Abbvie Inc | ||||
Operating Margin
D.Western Therapeutics Institute Inc
-159.9%
ABBV
34.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc | ||||
|
|
Abbvie Inc | ||||
Net Margin
D.Western Therapeutics Institute Inc
-163.1%
ABBV
6.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc | ||||
|
|
Abbvie Inc | ||||
FCF Margin
D.Western Therapeutics Institute Inc
-128.1%
ABBV
29.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc | ||||
|
|
Abbvie Inc | ||||
ROE
D.Western Therapeutics Institute Inc
-58.3%
ABBV
15 221.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc | ||||
|
|
Abbvie Inc | ||||
ROA
D.Western Therapeutics Institute Inc
-32.9%
ABBV
3.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc | ||||
|
|
Abbvie Inc | ||||
ROIC
D.Western Therapeutics Institute Inc
-123.9%
ABBV
14%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc | ||||
|
|
Abbvie Inc | ||||
ROCE
D.Western Therapeutics Institute Inc
-35.4%
ABBV
22.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
D
|
D.Western Therapeutics Institute Inc | ||||
|
|
Abbvie Inc | ||||
Solvency Comparison
D
D.Western Therapeutics Institute...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
4576, ABBV
4576, ABBV
Performance Gap
4576, ABBV
4576, ABBV
Performance Gap Between 4576 and ABBV
HIDDEN
Performance By Year
4576, ABBV
4576, ABBV
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 4576 to other stocks
PNEXF
Pharnext SCA
More expensive
vs D.Western Therapeutics Institu...
AMGN
Amgen Inc
Cheaper
vs D.Western Therapeutics Institu...
GILD
Gilead Sciences Inc
Cheaper
vs D.Western Therapeutics Institu...
VRTX
Vertex Pharmaceuticals Inc
Cheaper
vs D.Western Therapeutics Institu...
Select Stock to Compare
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
|
| US |
S
|
Seagen Inc
F:SGT
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
